Purchase Order HHSN268201600214A

Award Date 7/29/16
Potential Completion Date 7/28/18
Potential Value $142K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract, awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Cartagenia, Inc., a for-profit organization, is for a firm fixed-price purchase order with a ceiling value of $103,500.00. The contract has a completion date of July 12, 2016 and was awarded on July 13, 2015. This contract does not have a set-aside designation. The contract does not appear to be associated with a larger contract vehicle, and no subcontractors are mentioned. Based on the...
This federal contract award, valued at $76,361.60, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The award is a Delivery Order placed under the Multiple Award Schedule (MAS) contract vehicle. The contract was awarded to Government Scientific Source Inc., a for-profit small business organization, to provide a single-cell multiome reagent bundle, single-cell 3' kit V3.1, Chip G kit, Chip J kit, single...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. government, awarded a $229,104 firm fixed-price purchase order contract to Psomagen Inc., a for-profit organization and manufacturer of goods. The contract, which has no set-aside designation, is for investigating transthyretin (TTR) variants and their impact on sickle cell disease severity using Olink proteomics technology. This contract is part of a larger $500 million single-award Indefinite Delivery...
The National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded a $10,620 firm fixed price purchase order to Proteogenix, a for-profit manufacturer of biotechnology products and services. The contract provides additional laboratory screening services to support the development of novel gene therapy by the NHLBI's Center for Molecular Therapeutics and Bioanalytics (CMTB). This award is not associated with a larger contract vehicle and does not have...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $119,840.00 firm fixed price purchase order to Cofactor Genomics, Inc., a minority-owned, self-certified small disadvantaged business, for DNA methylation sequencing profiles. The contract has a completion date of August 29, 2023. Cofactor Genomics, Inc. will perform the work in St. Louis, Missouri. The contract award resulted from a solicitation posted on July 8, 2021,...
This federal contract award, identified as HHSN268201200064C, was made by the National Heart Lung and Blood Institute (NHLBI), a civilian agency of the U.S. government, to HDL Apomics LLC, a small business. The $139,291.00 Firm Fixed Price contract is for "OTHER FUNCTIONS-ANTIBODY PROTEOMICS FOR MEASURING LIPOPROTEIN SUB-POPULATIONS" under the SBIR TOPIC 64 PHASE 1 - NOVEL TECHNOLOGIES FOR ASSESSING LIPOPROTEIN SUB-FRACTIONS program. The contract has a total small business set-aside...
This federal contract award, with an ID of 75N92023A00020|75N92024F00001, was issued by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health, a civilian agency. The $392,338.51 Firm Fixed Price Blanket Purchase Agreement (BPA) call contract supports the National Human Genome Research Institute's (NHGRI) mission to train physicians in genetic and genomic medicine. The prime contractor is the ACMG Foundation for Genetic and Genomic Medicine, doing business...
This federal contract award, valued at $21,119.70, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the U.S. Department of Health and Human Services. The contract was awarded to Government Scientific Source Inc., a for-profit organization that specializes in providing laboratory products and equipment to federal agencies. The purpose of this contract is to supply reagents for sequencing to support ongoing clinical research at NHLBI to understand rare and...
This is a federal contract award from the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services (HHS), to a small, woman-owned, minority-owned business named LI, Lina. The contract has a firm fixed price of $319,857.12 and an ultimate completion date of October 14, 2018. The contract was awarded on July 1, 2016 and was not set aside for any specific business type. Without additional details on the original solicitation, the specific...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order to Cofactor Genomics, Inc., a minority-owned, self-certified small disadvantaged business, in the amount of $411,950.00. The contract is for the provision of DNA methylation libraries, Illumina sequencing, FASTQ raw sequence files, and Bismark summary files. The work is to be performed in St. Louis, Missouri, with a completion date of...

This is a federal contract award made by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to Cofactor Genomics, Inc. The contract has a firm fixed price of $141,524.00 and a period of performance ending on July 28, 2018. The contract is not set aside for any specific business type. Cofactor Genomics, Inc. is a minority-owned, self-certified small disadvantaged business. This contract award is not associated with a larger contract vehicle. The NHLBI supports research aimed at enhancing the understanding, prevention, and treatment of heart, lung, blood, and sleep disorders.

Generated 4/1/25, 6:46 PM